Short‐chain fatty acids in multiple sclerosis: Associated with disability, number of T2 lesions, and inflammatory profile
2025 · Annals of Clinical and Translational Neurology · 4 citations
https://doi.org/10.1002/acn3.52259
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
1
Papers
4
Citations
1
h-index
0
i10-index
Daniel López‐Mecández is an academic researcher from Hospital Clínico San Carlos. The author has contributed to research in topics: Multiple Sclerosis Research Studies & Immune Response and Inflammation & Cytokine Signaling Pathways and Interactions. The author has an h-index of 1, co-authored 1 publications.
Click to start Chat